Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00975949 · ClinicalTrials.gov registry record
Neurodevelopmental Outcomes and Fluconazole Prophylaxis
A clinical trial, sponsored by University of Virginia.
- Completed
- Registry status
- 39
- Enrollment target
NCT00975949: Completed study, sponsored by University of Virginia.
NCT00975949 is a clinical trial that has completed, run by University of Virginia. The registered enrollment target is 39 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00975949 has completed, sponsored by University of Virginia.
- COMPLETED
- Registry status
- 39 participants
- Enrollment target
Study Summary
The purpose of this study is to compare the neurodevelopmental outcome and quality of life between the fluconazole-treated and the placebo-treated patients that were enrolled in a fluconazole prophylaxis study that occurred in the investigators' neonatal intensive care unit (NICU) between 1998-2000.
Interventions
- OTHER Survey
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 39 participants |
| Start Date | 2008-06 |
| Est. Completion | 2010-06 |
What the finished NCT00975949 record still lists
NCT00975949 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 39 participants, a relatively small participant target.
The record links to 0 conditions, and to 1 intervention - of which Survey is the first listed.
NCT00975949 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00975949 about?
NCT00975949 is a clinical study titled "Neurodevelopmental Outcomes and Fluconazole Prophylaxis". The purpose of this study is to compare the neurodevelopmental outcome and quality of life between the fluconazole-treated and the placebo-treated patients that were enrolled in a fluconazole prophylaxis study that occurred in the investigators' neonatal intensive care unit (NICU) between 1998-2000.
What is the current status of trial NCT00975949?
This trial is currently completed. The enrollment target is 39 participants. The study started on 2008-06. Estimated completion is 2010-06.
What interventions are being tested in trial NCT00975949?
The interventions under investigation include: Survey (OTHER).
Who is sponsoring clinical trial NCT00975949?
This trial is sponsored by University of Virginia, which has 449 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03465592 · 39 participants · Phase 1
Trial of Nivolumab Following Partially Human Leukocyte Antigen (HLA) Mismatched BMT in Children & Adults With Sarcoma
- NCT03961776 · 39 participants
Monitoring Treatment Response With On-board DWI During Neo-adjuvant Chemo-radiation for Rectal Cancer Using Magnetic Resonance-guided-radiotherapy Systems
- NCT04050280 · 39 participants · Phase 2
CLAG-GO for Patients With Persistent, Relapsed or Refractory AML
- NCT04190862 · 39 participants · Phase 1
E-CEL UVEC as an Adjunct Cell Therapy for Treatment of Anal Fistulas
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia